Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology/Urology
Clinical Trials: Liver Cancer
A listing of clinical trials currently looking for volunteers to enroll in Liver Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
Birmingham : University of Alabama at Birmingham Comprehensive Cancer Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
View More »
Birmingham : UAB
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Phoenix : Mayo Clinic Arizona
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Phoenix : Mayo Clinic Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Duarte : City of Hope Updated
A Treatment of Unresectable Hepatocellular Carcinoma with TheraSphere (Yttrium-90 Glass Microspheres): A HDE Treatment Use Protocol
Duarte : City of Hope Updated
PHI-64, NCI #8155; A Phase I Trial of Escalating Doses of the Anti-IGF-1R Monoclonal IMC-A12 and Standard Dose Sorafenib for Treatment of Advanced Hepatocellular Carcinoma
Duarte : City of Hope Updated
PHII-105: NCI #8752 A Phase II Study of MK-2206 in Patients with Advanced Hepatocellular Carcinoma who have Failed or are Intolerant of One Prior Line of Anti-Angiogenic Therapy
Los Angeles : USC Norris Comprehensive Cancer Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
San Francisco : California Pacific Medical Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
San Francisco : California Pacific Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
View More »
La Jolla : Moores University of California San Diego Cancer Center Updated
A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer
Orange : University of California Irvine Medical Center
TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
San Francisco : California Pacific Medical Center Updated
A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer
Stanford : Stanford Hospital and Clinics Updated
A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer
Gainesville : University of Florida College of Medicine
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Miami : University of Miami School of Medicine
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Atlanta : Winship Cancer Institute of Emory University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Atlanta : Piedmont Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Savannah : Memorial Health University Medical Center
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer AHEP0731
Savannah : Memorial Health University Medical Center
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer AHEP0731
Savannah : Memorial Health University Medical Center
Trial NCT01015833 Phase III Randomized Study of Sorefenib Plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) CALGB 80802
View More »
Atlanta : Emory University Winship Cancer Institute
A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer
Honolulu : Hawaii Medical Center East
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Westwood : University of Kansas Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Louisville : University of Louisville - Surgery
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Louisville : University of Louisville
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
New Orleans : Tulane University Health Services Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
New Orleans : Tulane University Health Services Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
New Orleans : Tulane Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Baltimore : Mercy Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Boston : Massachusetts General Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Boston : Dana-Farber Cancer Institute
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Boston : Beth Israel Deaconess Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Detroit : Henry Ford Health System
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Minneapolis : University of Minnesota Cancer Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Minneapolis : University of Minnesota Medical Center-Fairview
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Billings : Billings Clinic Updated
A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer
New Brunswick : Robert Wood Johnson University Hospital
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
New Brunswick : The Cancer Institute of New Jersey
Measurement of Pro-antiangiogenic Markers in Patients With Hepatic Metastases Undergoing Selective Internal Radiation Therapy (SIRT)
Albuquerque : University of New Mexico Cancer Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Bronx : Biomedical Research Alliance of New York
Colorectal Liver Metastases Study
Buffalo : Roswell Park Cancer Institute
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
New York : Mount Sinai School of Medicine
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
New York : Mount Sinai School of Medicine
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
New York : Mount Sinai Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Rochester : University of Rochester Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Charlotte : Carolinas Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
View More »
Chapel Hill : UNC - CH Department of Surgery
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Cleveland : Experimental Therapeutics Program
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Portland : OHSU
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
View More »
Portland : Providence Portland Medical Center
Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures
Philadelphia : Thomas Jefferson University Hospitals
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Pittsburgh : UPMC Liver Cancer Center
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
View More »
Philadelphia : Thomas Jefferson University
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
Pittsburg : UPMC, Montefiore Hospital Liver Cancer Center
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Houston : S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 In Patients With Primary Liver Cancer
View More »
Houston : UT MD Anderson Cancer Center
4D PET/CT Imaging in Lung and Colorectal Cancer With Liver Metastasis
Houston : UT MD Anderson Cancer Center
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Houston : UT MD Anderson Cancer Center
Humanitarian Device Exemption (HDE) Treatment Protocol
Richmond : McGuire D.V.A.M.C. GI (111N)
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Richmond : McGuire D.V.A.M.C. GI (111N)
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seattle : Seattle Cancer Care Alliance / University of Washington
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seattle : Seattle Cancer Center Alliance
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Morgantown : West Virginia University - Clinical Trials Research Unit
DEFIBROTIDE2006-05 -Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study (Under CRF 312.34)
Buenos Aires : Hospital Universitario Austral
Unidad de Investigación Clínica
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Ciudad Autonoma De Buenos Aires : Hospital Británico de Buenos Aires
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Ciudad Autonoma De Buenos Aires : Hospital Italiano de Buenos Aires
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
ROSARIO Pcia. de Santa Fe : Hospital Provincial del Centenario
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Brisbane : Greenslopes Private Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Camperdown, New South Wales : Royal Prince Alfred Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Clayton : Monash Medical Centre
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Greenslopes, Queensland : Greenslopes Private Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Herston, Queensland : Royal Brisbane and Women's Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Melbourne, Victoria : Austin Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Nedlands, Western Australia : Sir Charles Gairdner Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Prahran, Victoria : The Alfred Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Prahran, Victoria : The Alfred Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Randwick : Prince of Wales Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Randwick, New South Whales : The Prince of Wales Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Linz : Krankenhaus der Elisabethinen Linz GmbH
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
nnsbruck : Medizinische Universität Innsbruck
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Wien : Medizinische Universität Wien
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Brussels : Cliniques Universitaires Saint-Luc
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Bruxelles : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Edegem : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Ghent : University Hospital Ghent
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Ghent : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Kortrijk : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
La Louviere : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Leuven : Universitair Ziekenhuis Gasthuisberg
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Leuven : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Liège : C.H.U. de Liège
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Liège : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Plovdiv : District Dispensary for Oncology Diseases with Inpatient Unit
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Plovdiv : District Dispensary for Oncology Diseases with Inpatient
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Sofia : District Dispensary for Oncology Diseases with Inpatient
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Varna : Inter-district Dispensary for oncology disease with inpatient unit "Dr Marko Markov"
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Varna : Interdistrict Dispensary for Oncological Diseases Dr.M.Marko
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Varna : MHAT Sveta Marina
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Edmonton, Alberta : Cross Cancer Institute
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Halifax, Nova Scotia : Queen Elizabeth II Health Sciences Centre
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Vancouver, British Columbia : British Columbia Cancer Agency
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
View More »
Ottawa : Ottawa Hopsital Research Institute Updated
A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer
Santiago : Instituto Nacional del Cancer
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Santiago : Hospital Barros Luco Trudeau
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Temuco : Hospital Regional De Temuco
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Anhui : 1st Hospital Anhui Med. University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : 301 Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : Shan'xi Provincial People's Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : 3rd Xiangya Hospital of C.S.University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : 307 Hospital of PLA
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : Cancer Hospital, Chinese Medical Science Institute
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : Beijing Cancer Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : Beijing Cancer Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : 1st Aff Hosp Xi’an Jiaotong
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : Southwest Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beijing : Beijing Cancer Institute&Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Beijing : 307 Hospital of PLA
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Cheng Du : West China Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Guangdong : Nanfang Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Guangdong : The First Affiliated Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Guangdong : Cancer Hospital Sun Yat-sen University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Guangxi : Guangxi Medical University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Guangzhou : Guangdong General Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Guangzhou : Sun Yat-sen University Cancer Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Hangzhou : Sir Run Run Shaw Hosp Med College of Zhejiang University
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Hubei : Union Hospital of Huazhong University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Hubei : Tongji Hospital of Huazhong University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Hunan Province : Xiangya Hospital of C.S.University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Hunan, : Tumor Hos of Hunan Province
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Jiangsu : Nanjing 81 hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Liaoning : 2nd Aff.Hospital, Dalian Med. University
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Nanjing : Nanjing 81 hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Shan Xi : Tangdu Hospital of 4th Military
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Shanghai : Renji Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Shanghai : Shanghai Eastern Hepatobiliary Surgery Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Sichuan Province : Sichuan Provincial People's
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Tian Jin : Tianjin Cancer Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Zhejiang : Zhejiang Cancer Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Angers : CHU d'Angers
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Bondy : Hôpital Jean Verdier
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Bordeaux : Hôpital Saint André
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Bordeaux : Hôpital Saint André - Bordeaux
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Cédex : Hôpital l'Archet 2
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Clichy : Hôpital Beaujon - Clichy
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Créteil : Hôpital Henri Mondor
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Créteil : Hôpital Henri Mondor -
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
La-Roche-sur-Yon : Centre Hospitalier Départemental- La-Roche-sur-Yon
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Lille : Hôpital Claude Huriez
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Lille : Hôpital Claude Huriez
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Lyon : Hôtel Dieu
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Lyon : Hôtel Dieu - Lyon
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Marseille : CHU La Timone
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Marseille : Hôpital de la Timone -
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Paris : Hôpital Tenon
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Paris : Hôpital Saint-Antoine
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Paris : Hôpital Saint Antoine - Paris
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Pessac : Hopital du Haut Leveque - Pessac
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Rennes : Centre Eugène Marquis
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Toulouse : Hôpital Purpan - Pavillon Dieulafoy
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Vandoeuvre-lès-Nancy : CHU Nancy-Brabois, Hôpital d’Adultes
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Vandoeuvre-lès-Nancy : CHU Brabois - Vandoeuvre-les-Nancy
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Villejuif : Hôpital Paul Brousse
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Villejuif : Hôpital Paul Brousse -
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Berlin : Charite - Unversitatsmedizin Berlin
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Berlin : Charité Universitätsmedizin Berlin Campus Benjamin Franklin
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Düsseldorf : Universitätsklinikum Düsseldorf
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Essen : Universitatsklinikum Essen
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Essen : Medizinische Einrichtungen der Universität Essen
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Frankfurt : Klinikum der Johann Wolfgang Goethe Universität
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Freiburg : Universitatsklinikum Freiburg
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Freiburg : Kliniken und Polikliniken der Albert-Ludwigs-Universität
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Gottingen : Universitatsmedizin Gottingen
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Hamburg : Universitätsklinikrn Hamburg-Eppendorf
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Hannover : Medizinische Hochchule Hannover
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Hannover : Kliniken der Medizinischen Hochschule Hannover
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Homburg : Universitätskliniken des Saarlandes
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Homburg/Saar : Universitatsklinikum des Saarlands
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Köln : Medizinische Einrichtungen der Universität zu Köln
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Magdeburg : Universitatsklinikum Magdeburg AoR
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Mainz : Klinikum der Johannes Gutenberg-Universität MainzI
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Mainz : Klinikum der Johannes-Gutenberg-Universitität
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
München : Klinikum der Universitat Munchen-Grosshadern
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
München : Klinikum rechts der Isar
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Regensburg : Klinikum der Universitat Regensburg
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Regensburg : Klinikum der Universität Regensburg
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Tübingen : Klinikum der Eberhard-Karls-Universität Tübingen
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Hong Kong : Queen Mary Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Beersheva : Soroka University Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Haifa : Rambam Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Petach Tikva : Rabin Medical Center - Beilinson Campus
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Rehovot : Kaplan Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Tel Hashomer : Chaim Sheba Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Zrifin : Assaf Harofeh Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Bari : Sezione Chirurgia Generale e Trapianti di Fegato - Policlinico di Bari
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Benevento : Azienda Ospedaliera "G. Rummo" - Unità Operativa di Oncologia Medica
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Bologna : Azienda Ospedaliera Universitaria di Bologna – Policlinico S. Orsola-Malpighi
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Cagliari : Ospedale A. Businco
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Catania : Azienda Ospedaliera Garibaldi-Nesima - Unità di Epatologia
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Milan : National institute for cancer,
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Milan : Ospedale Fatebenefratelli ed oftalmico,
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Modena : Dipartimento Integrato di Medicina e Specialità Mediche - Unità Complessa di Gastroenterologia
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Napoli : Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale"
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Napoli : Ospedale Fatebenefratelli - Dipartimento Medicina Interna - Centro per le malattie del fegato
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Padova : Azienda Ospedaliera Università di Padova
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Palermo : Azienda Ospedaliera Universitaria "Paolo Giaccone”
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Roma : Policlinico Agostino Gemelli - Universita' Cattolica
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Torino : Ospedale San Giovanni Battista,
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seoul : Korea University Guro Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Seoul : Gangnam Severance Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Seoul : Seoul St. Mary Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Suwon : Ajou University Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Auckland : New Zealand Liver Transplant Unit
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Bydgoszcz : Centrum Onkologii im. Prof. Franciszka Lukaszczyka
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Gdansk : Samodzielny Publiczny Szpital Kliniczny nr 1 ACK AMG
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Gliwice : Centrum Onkologii - Instytut
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Warszawa : Centrum Onkologii - Instytut im. M.Sklodowskiej-Curie
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Barnaul : Altay Oncological Dispensary
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Kazan : Clinical Oncology Dispensary
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Moscow : Russian Scientific Oncology Centre n.a. N.N Blockhin of RAMS
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Nizhniy Novgorod : Privolzhskiy Okruzhnoy Medical Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
St Petersburg : City Clinical Oncology Centre
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Yaroslavl : Clinical Oncology Hospital
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Singapore : Singapore General Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Singapore : National Cancer Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Singapore : Johns Hopkins Singapore IMC
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
View More »
Singapore :
A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma
Johannesburg : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Mayville, Durban : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Newtown Park, Port Elizabeth : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Panorama, Cape Town : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Busan : Pusan National University Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Daegu : Kyungpook National University Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Gyeonggi-do : National Cancer Centre
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Gyeonggi-do : Inje University Ilsan Paik Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Jeonbuk : Chonbuk National University Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seoul : Asan Medical Centre
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seoul : Seoul National University Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seoul : Samsung Medical Centre
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seoul : Gangnam Severance Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Seoul : Severance Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Singapore : National University Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Barcelona : Hospital Clínic i Provincial de Barcelona
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Barcelona : Instituto Catalan de Oncologia
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Barcelona : Hospital Clínic i Provincial de Barcelona
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Lugo : Complejo Hospitalario Xeral Calde
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Madrid : Hospital Infanta Sofía
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Madrid : Hospital Clínico Universitario San Carlos
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Madrid : Hospital Universitario 12 de Octubre
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Madrid : Hospital Infanta Sofía
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Málaga : Hospital Virgen de la Victoria
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Santander : Hospital Universitario "Marqués de Valdecilla"
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Santander : Hospital Universitario "Marqués de Valdecilla"
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Valencia : Hospital Clínico Universitario de Valencia
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Valencia : Hospital Universitario La Fe
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Goteborg : Sahlgrenska University hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Stockholm : Karolinska University hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Changhua City : Changhua Christian Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Kaohsiung : Chang Gung Memorial Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Kaohsiung City : E-Da Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Kwei-Shan : Chang Gung Memorial Hospital-Linkou Medical Centre Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Taichung : China Medical University Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
View More »
Taichung : Taichung Veterans General Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Tainan : National Cheng Kung University Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Taipei : National Taiwan University Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
Taipei : Shin Kong Wu Ho-Su Memorial Hospital
Phase II/III Trial of Hepatocellular Carcinoma Patients Treated by ex Vivo Expanded Autologous Immune Killer Cells as the Adjunct Therapy
Taipei City : Taipei Veterans General Hospital Updated
A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection
TPE : National Taiwan University Hospital Updated
A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer
Birmingham : CRUK Institute for Cancer Studies
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
Glasgow : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
London : Royal Free Hampstead NHS Trust
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
London : Kings College Hospital
A study to determine whether a drug, sorafenib, is effective in the adjuvant treatment of liver cancer.
London : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Newcastle Upon Tyne : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
Sheffield : Research Center
This is a Phase III trial designed to evaluate an oral sorafenib combination treatment for advanced liver cancer. Liver cancer patients with disease that is not curable by surgical methods or treatable by local therapy are eligible.
